CVS Health enters biosimilar fray with launch of new subsidiary
Corvadis is already underway in its mission, having contracted with Sandoz to commercialise and market Hyrimoz (adalimumab-adaz), a Humira biosimilar.
Read MoreCorvadis is already underway in its mission, having contracted with Sandoz to commercialise and market Hyrimoz (adalimumab-adaz), a Humira biosimilar.
Read MoreA new report from the Congressional Research Service (CRS) offers an overview of challenges facing the nation’s hemp industry as
Read MoreIn March, the Big Three manufacturers of insulin, who control over 90% of the insulin market in the U.S., announced
Read MoreCNN — The US Food and Drug Administration has issued a warning against buying or using certain eye drops from
Read MoreLINCOLN, Neb. (KLKN) – It can take only minutes to experience symptoms of heat illnesses if you are not properly
Read MoreFaster, more cost-effective process touted as ‘significant advancement’ for the worldwide supply chain WEST LAFAYETTE, Ind. – The COVID-19 pandemic
Read MoreFor six decades, there was no approved vaccine for one of the most common causes of severe illness in infants,
Read MoreINDIANAPOLIS (WISH) — Doctors are warning parents about the growing danger of young children swallowing button batteries. Health officials say
Read MoreObesity and type 2 diabetes (T2D) drugs have provided significant increases in revenue growth. Credit: encierro via Shutterstock. Novo Nordisk
Read MoreIn this courtroom sketch, FTX cryptocurrency exchange founder Sam Bankman-Fried, wearing prison clothing, stands between his attorneys Mark Cohen and
Read More